Seki Y - Search Results

1

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors.

Seki Y, Yamamoto N, Tamura Y, Goto Y, Shibata T, Tanioka M, Asahina H, Nokihara H, Yamada Y, Shimamoto T, Noguchi K, Tamura T. Seki Y, et al. Cancer Chemother Pharmacol. 2012 Apr;69(4):1099-105. doi: 10.1007/s00280-011-1788-4. Epub 2011 Dec 6. Cancer Chemother Pharmacol. 2012. PMID: 22143378 Free PMC article. Clinical Trial.

2

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.

Asahina H, Tamura Y, Nokihara H, Yamamoto N, Seki Y, Shibata T, Goto Y, Tanioka M, Yamada Y, Coates A, Chiu YL, Li X, Pradhan R, Ansell PJ, McKeegan EM, McKee MD, Carlson DM, Tamura T. Asahina H, et al. Among authors: seki y. Cancer Chemother Pharmacol. 2012 Jun;69(6):1477-86. doi: 10.1007/s00280-012-1846-6. Epub 2012 Mar 2. Cancer Chemother Pharmacol. 2012. PMID: 22382879 Free PMC article. Clinical Trial.

3

Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.

Asahina H, Nokihara H, Yamamoto N, Yamada Y, Tamura Y, Honda K, Seki Y, Tanabe Y, Shimada H, Shi X, Tamura T. Asahina H, et al. Among authors: seki y. Invest New Drugs. 2013 Jun;31(3):677-84. doi: 10.1007/s10637-012-9860-4. Epub 2012 Jul 28. Invest New Drugs. 2013. PMID: 22843211 Clinical Trial.

4

Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.

Seki Y, Fujiwara Y, Kohno T, Takai E, Sunami K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Watanabe S, Ichikawa H, Yamamoto N, Kuwano K, Ohe Y. Seki Y, et al. Oncologist. 2016 Feb;21(2):156-64. doi: 10.1634/theoncologist.2015-0288. Epub 2016 Jan 14. Oncologist. 2016. PMID: 26768482 Free PMC article.

5

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.

Yamamoto N, Nokihara H, Yamada Y, Shibata T, Tamura Y, Seki Y, Honda K, Tanabe Y, Wakui H, Tamura T. Yamamoto N, et al. Among authors: seki y. Invest New Drugs. 2017 Apr;35(2):207-216. doi: 10.1007/s10637-016-0411-2. Epub 2016 Dec 8. Invest New Drugs. 2017. PMID: 27928714 Free PMC article. Clinical Trial.

6

Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression.

Seki Y, Fujiwara Y, Kohno T, Yoshida K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Yamamoto N, Kuwano K, Ohe Y. Seki Y, et al. ESMO Open. 2018 Feb 8;3(2):e000292. doi: 10.1136/esmoopen-2017-000292. eCollection 2018. ESMO Open. 2018. PMID: 29464111 Free PMC article.

7

Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study.

Seki Y, Yoshida T, Kohno T, Masuda K, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Kuwano K, Ohe Y. Seki Y, et al. Respir Investig. 2022 Nov;60(6):852-856. doi: 10.1016/j.resinv.2022.08.002. Epub 2022 Sep 9. Respir Investig. 2022. PMID: 36089506

8

Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.

Seki Y, Okusaka T, Ikeda M, Morizane C, Ueno H. Seki Y, et al. Jpn J Clin Oncol. 2009 Nov;39(11):751-5. doi: 10.1093/jjco/hyp085. Epub 2009 Aug 8. Jpn J Clin Oncol. 2009. PMID: 19666905

9

Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma.

Yamanaka Y, Seki Y, Ishikawa T, Kuwano K. Yamanaka Y, et al. Among authors: seki y. BMJ Case Rep. 2019 Jan 31;12(1):e227383. doi: 10.1136/bcr-2018-227383. BMJ Case Rep. 2019. PMID: 30709831 Free PMC article.

10

Clinical utility of thoracoscopy in elderly tuberculous pleurisy patients under local anesthesia.

Fujimoto S, Saito K, Matsubayashi S, Sato A, Yamada M, Yamanaka Y, Fujisaki I, Odashima K, Seki A, Kazuyori T, Seki Y, Takeda H, Ishikawa T, Inagaki T, Sato S, Kuwano K. Fujimoto S, et al. Among authors: seki y, seki a. J Infect Chemother. 2021 Jan;27(1):40-44. doi: 10.1016/j.jiac.2020.08.008. Epub 2020 Aug 23. J Infect Chemother. 2021. PMID: 32847717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters